Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wasserman

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Plos One|August 31, 2013
CCDC65 mutation causes primary ciliary dyskinesia with normal ultrastructure and hyperkinetic ciliaAmjad Horani, Steven L Brody, Thomas W Ferkol, et al.
American Heart Journal|August 30, 2001
The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) TrialM A Pfeffer, M Domanski, J Verter, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 12, 2000
Measuring contributions to the clinical mission of medical schools and teaching hospitalsR M D'Alessandri, P Albertsen, B F Atkinson, et al.
Molecular Medicine (Cambridge, Mass.)|March 28, 2026
CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditionsJoel F Cohen-Solal, Calvin S Pohl, Sheila M Cummings, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Plos One|August 31, 2013
CCDC65 mutation causes primary ciliary dyskinesia with normal ultrastructure and hyperkinetic ciliaAmjad Horani, Steven L Brody, Thomas W Ferkol, et al.
American Heart Journal|August 30, 2001
The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) TrialM A Pfeffer, M Domanski, J Verter, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 12, 2000
Measuring contributions to the clinical mission of medical schools and teaching hospitalsR M D'Alessandri, P Albertsen, B F Atkinson, et al.
Molecular Medicine (Cambridge, Mass.)|March 28, 2026
CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditionsJoel F Cohen-Solal, Calvin S Pohl, Sheila M Cummings, et al.
Pageof 11